After-hours movers: GameStop, Dave & Buster's, Viridian Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Viridian Therapeutic (VRDN) PT Raised to $31 at Goldman Sachs
September 12, 2024 5:07 AM EDTGoldman Sachs analyst Richard Law raised the price target on Viridian Therapeutic (NASDAQ: VRDN) to $31.00 (from $25.00) while maintaining a Buy rating.
The analyst comments "We update our model to reflect increased POS for veligrotug (VRDN-001) following positive topline results from the Ph. 3 THRIVE... More
William Blair Reiterates Outperform Rating on Dave & Buster's (PLAY)
September 11, 2024 6:58 AM EDTWilliam Blair analyst Sharon Zackfia reiterated an Outperform rating and {REMOVEPT} price target on Dave & Buster's (NASDAQ: PLAY)
The analyst comments "Given challenging near-term trends, we continue to expect negative comps to persist through the remainder of fiscal 2024, yielding an approximate 5% same-store... More
Truist Securities Reiterates Buy Rating on Dave & Buster's (PLAY)
September 11, 2024 5:15 AM EDTTruist Securities analyst Jake Bartlett reiterated a Buy rating and $59.00 price target on Dave & Buster's (NASDAQ: PLAY).
The analyst comments "We expect sales initiatives will start to offset macro headwinds, especially in 4Q24: We attribute slowing SSS in 2Q24 (now slightly below '19 levels on a compounded basis) to macro pressures, which have overwhelmed PLAY's sales drivers to date,... More
BMO Capital Reiterates Outperform Rating on Dave & Buster's (PLAY)
September 11, 2024 5:13 AM EDTBMO Capital analyst Andrew Strelzik reiterated an Outperform rating and $55.00 price target on Dave & Buster's (NASDAQ: PLAY).
The analyst comments "FY2Q24 EBITDA of $152 million exceeded consensus by $11 million as stronger restaurant margins and lower G&A more than offset softer comps.... More
